Drug-induced interstitial lung disease: Indictment for apixaban

被引：0
|
作者：
Capron, Thibaut [1 ]
Botto, Guillaume [1 ]
Roujon, Jean-Jacques [1 ]
Miltgen, Jean [1 ]
Berard, Henri [1 ]
机构：
[1] Elsan Polyclin Fleurs, Cabinet Pneumol, Ollioules, France
来源：
RESPIRATORY MEDICINE AND RESEARCH | 2023年 / 84卷
关键词：
Drug-induced interstitial lung disease; Apixaban; Direct oral anticoagulants; Adverse event;
D O I：
10.1016/j.resmer.2023.101024
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Interstitial Lung Disease Induced by Pazopanib Treatment
    Ide, Shotaro
    Sakamoto, Noriho
    Hara, Shintaro
    Hara, Atsuko
    Kakugawa, Tomoyuki
    Nakamura, Yoichi
    Futsuki, Yoji
    Izumikawa, Koichi
    Ishimatsu, Yuji
    Yanagihara, Katsunori
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2017, 56 (01) : 79 - 83
  • [32] Pneumocystis pneumonia in everolimus therapy: An indistinguishable case from drug induced interstitial lung disease
    Suzuki, Toshio
    Tada, Yuji
    Tsushima, Kenji
    Terada, Jiro
    Sakurai, Takayuki
    Watanabe, Akira
    Kasahara, Yasunori
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    RESPIRATORY MEDICINE CASE REPORTS, 2013, 10 : 27 - 30
  • [33] Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
    Hotta, Takamasa
    Okimoto, Tamio
    Hamaguchi, Megumi
    Tsubata, Yukari
    Isobe, Takeshi
    INTERNAL MEDICINE, 2020, 59 (02) : 253 - 256
  • [34] Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
    Sato, Shintaro
    Oba, Tomohiro
    Ohta, Hiroki
    Tsukahara, Yuta
    Kida, Gen
    Tsumiyama, Emiri
    Kusano, Kenji
    Nishizawa, Tomotaka
    Kawabe, Rie
    Yamakawa, Hideaki
    Akasaka, Keiichi
    Amano, Masako
    Matsushima, Hidekazu
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [35] Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer
    Sakurada, Takumi
    Kakiuchi, Soji
    Tajima, Soichiro
    Horinouchi, Yuya
    Okada, Naoto
    Nishisako, Hirotaka
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Kawazoe, Kazuyoshi
    Yanagawa, Hiroaki
    Nishioka, Yasuhiko
    Minakuchi, Kazuo
    Ishizawa, Keisuke
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 398 - 404
  • [36] COVID-19 vaccine induced interstitial lung disease
    Yoshifuji, Ayumi
    Ishioka, Kota
    Masuzawa, Yuya
    Suda, Shuntaro
    Murata, Saori
    Uwamino, Yoshifumi
    Fujino, Motoko
    Miyahara, Hiromi
    Hasegawa, Naoki
    Ryuzaki, Munekazu
    Hoshino, Haruhiko
    Sekine, Kazuhiko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 95 - 98
  • [37] Lemborexant-induced interstitial lung disease: A case report
    Nakahara, Satoshi
    Ishii, Yumiko
    Egashira, Reika
    Tsubouchi, Kazuya
    Kohno, Mikihiro
    Takenaka, Tomoyoshi
    Tanaka, Kentaro
    Okamoto, Isamu
    RESPIROLOGY CASE REPORTS, 2024, 12 (05):
  • [38] An update on interstitial lung disease
    Mudawi, D.
    Heyes, K.
    Hastings, R.
    Rivera-Ortega, P.
    Chaudhuri, N.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (07)
  • [39] Elotuzumab-induced interstitial lung disease: the first case report
    Tanaka, Toru
    Saito, Yoshinobu
    Kokuho, Nariaki
    Tamura, Hideto
    Terasaki, Yasuhiro
    Seike, Masahiro
    Gemma, Akihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (05) : 491 - 494
  • [40] Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy
    Kaburaki, Shota
    Okada, Naoko
    Tanaka, Toru
    Kamio, Koichiro
    Tanaka, Yosuke
    Terasaki, Yasuhiro
    Kasahara, Kazuo
    Seike, Masahiro
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
12345